PortfoliosLab logoPortfoliosLab logo
NFLX vs. CPRX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NFLX vs. CPRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Netflix, Inc. (NFLX) and Catalyst Pharmaceuticals, Inc. (CPRX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NFLX achieves a -27.90% return, which is significantly lower than CPRX's 34.92% return. Over the past 10 years, NFLX has underperformed CPRX with an annualized return of 22.91%, while CPRX has yielded a comparatively higher 44.91% annualized return.


NFLX

1D
-1.96%
1M
-12.64%
6M
-23.18%
YTD
-27.90%
1Y
-44.10%
3Y*
16.50%
5Y*
5.65%
10Y*
22.91%
ALL TIME*
30.17%

CPRX

1D
0.00%
1M
0.35%
6M
38.72%
YTD
34.92%
1Y
49.74%
3Y*
32.72%
5Y*
41.46%
10Y*
44.91%
ALL TIME*
8.79%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NFLX vs. CPRX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NFLX
Netflix, Inc.
-27.90%5.19%83.07%65.11%-51.05%11.41%67.11%20.89%39.44%55.06%
CPRX
Catalyst Pharmaceuticals, Inc.
34.92%11.84%24.15%-9.62%174.74%102.69%-10.93%95.31%-50.90%272.38%

Correlation

The correlation between NFLX and CPRX is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (10Y)
Calculated over the trailing 10-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Nov 8, 2006

0.14

The correlation between NFLX and CPRX shifts across timeframes, from -0.04 (1 year) to 0.22 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NFLX:

$284.65B

CPRX:

$3.85B

EPS

NFLX:

$3.17

CPRX:

$1.74

PE Ratio

NFLX:

21.32

CPRX:

18.08

PEG Ratio

NFLX:

0.84

CPRX:

0.32

PS Ratio

NFLX:

6.02

CPRX:

6.70

PB Ratio

NFLX:

9.55

CPRX:

3.95

Total Revenue (TTM)

NFLX:

$48.37B

CPRX:

$596.96M

Gross Profit (TTM)

NFLX:

$23.76B

CPRX:

$378.23M

EBITDA (TTM)

NFLX:

$30.55B

CPRX:

$313.50M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NFLX vs. CPRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NFLX
NFLX Risk / Return Rank: 33
Overall Rank
NFLX Sharpe Ratio Rank: 22
Sharpe Ratio Rank
NFLX Sortino Ratio Rank: 33
Sortino Ratio Rank
NFLX Omega Ratio Rank: 44
Omega Ratio Rank
NFLX Calmar Ratio Rank: 55
Calmar Ratio Rank
NFLX Martin Ratio Rank: 33
Martin Ratio Rank

CPRX

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NFLX vs. CPRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Netflix, Inc. (NFLX) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NFLXCPRXDifference
Sharpe ratioReturn per unit of total volatility

-2.81

Sortino ratioReturn per unit of downside risk

-4.12

Omega ratioGain probability vs. loss probability

0.75

1.31

-0.56

Calmar ratioReturn relative to maximum drawdown

-0.95

3.52

-4.47

Martin ratioReturn relative to average drawdown

-1.76

9.42

-11.18

NFLX vs. CPRX - Sharpe Ratio Comparison

The current NFLX Sharpe Ratio is -1.27, which is lower than the CPRX Sharpe Ratio of 1.54. The chart below compares the historical Sharpe Ratios of NFLX and CPRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NFLX vs. CPRX - Drawdown Comparison

The maximum NFLX drawdown since its inception was -81.99%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for NFLX and CPRX.


Loading charts...

Drawdown Indicators


NFLXCPRXDifference

Max Drawdown

Largest peak-to-trough decline

-81.99%

-94.25%

+12.26%

Max Drawdown (1Y)

Largest decline over 1 year

-46.49%

-13.91%

-32.58%

Max Drawdown (3Y)

Largest decline over 3 years

-49.52%

-27.29%

-22.23%

Max Drawdown (5Y)

Largest decline over 5 years

-75.95%

-45.37%

-30.58%

Max Drawdown (10Y)

Largest decline over 10 years

-75.95%

-64.87%

-11.08%

Current Drawdown

Current decline from peak

-49.52%

-0.03%

-49.49%

Average Drawdown

Average peak-to-trough decline

-24.98%

-51.73%

+26.75%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.06%

5.18%

+19.88%

Volatility

NFLX vs. CPRX - Volatility Comparison

Netflix, Inc. (NFLX) has a higher volatility of 13.34% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 0.41%. This indicates that NFLX's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NFLXCPRXDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.34%

0.41%

+12.93%

Volatility (6M)

Calculated over the trailing 6-month period

27.81%

21.80%

+6.01%

Volatility (1Y)

Calculated over the trailing 1-year period

34.79%

31.77%

+3.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.50%

47.65%

-4.15%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.38%

59.86%

-18.48%

Dividends

NFLX vs. CPRX - Dividend Comparison

Neither NFLX nor CPRX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

NFLX vs. CPRX - Financials Comparison

This section allows you to compare key financial metrics between Netflix, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B20222023202420252026
12.56B
149.39M
(NFLX) Total Revenue
(CPRX) Total Revenue
Values in USD except per share items

NFLX vs. CPRX - Profitability Comparison

The chart below illustrates the profitability comparison between Netflix, Inc. and Catalyst Pharmaceuticals, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%20222023202420252026
51.9%
0
Portfolio components
NFLX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Netflix, Inc. reported a gross profit of 6.52B and revenue of 12.56B. Therefore, the gross margin over that period was 51.9%.

CPRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Catalyst Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 149.39M. Therefore, the gross margin over that period was 0.0%.

NFLX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Netflix, Inc. reported an operating income of 4.19B and revenue of 12.56B, resulting in an operating margin of 33.4%.

CPRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Catalyst Pharmaceuticals, Inc. reported an operating income of 73.23M and revenue of 149.39M, resulting in an operating margin of 49.0%.

NFLX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Netflix, Inc. reported a net income of 3.40B and revenue of 12.56B, resulting in a net margin of 27.1%.

CPRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Catalyst Pharmaceuticals, Inc. reported a net income of 63.73M and revenue of 149.39M, resulting in a net margin of 42.7%.


Frequently Asked Questions


NFLX and CPRX have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NFLX has higher volatility (13.34%) compared to CPRX (0.41%). In terms of maximum drawdown, NFLX dropped -81.99% vs CPRX's -94.25%.

CPRX currently has the higher Sharpe Ratio (1.54 vs -1.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NFLX and CPRX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer